Group items tagged

Online pharmacy delivery partner Gophr has released new data showing a further drop in pharmacy numbers in England, resulting in a phenomenon they call 'Pharmacy Deserts'. Gophr highlighted that a significant portion of the population now lives in 'pharmacy deserts,' referring to the situation where an increasing number of urban residents struggle to access a shrinking number of pharmacies. For the second consecutive year, Gophr has analysed the data for its 'Prescription For Pressure' initiative. The analysis showed that in 2023, pharmacists dispensed 1.18 billion prescriptions across England, marking an increase of 137 million compared to 2022. The average number of prescriptions per pharmacy stands at 103,380, which equates to 283 a day. As calculated by Gophr's data experts, pharmacy numbers decreased from 11,522 in 2022 to 11,414 in 2023, reflecting a decline of 108 compared to the previous year's 'Prescription For Pressure'. Gophr's data also showed that pharmacy deserts are most prominent in the South East (6,024 people per pharmacy), the East of England (5,327), the South West (5,284), and the Midlands (4,975). London, which ranked high last year, fell out of the top four, with 4,759 people per pharmacy.

In the pharmaceutical industry, maintaining high standards for water quality is crucial for ensuring product safety, efficacy, and compliance with regulatory standards. Water is a fundamental ingredient in drug manufacturing, and its quality directly impacts the production process and the end products. This makes adherence to water service compliance a legal obligation and a critical aspect of operational integrity. THE LEGAL COMPLICATIONS OF POOR WATER QUALITY Compliance with water quality standards in the pharmaceutical industry is mandated by regulatory agencies such as the MHRA, several regulations that set strict criteria for the types of water used, including purified water, water for injection, and sterile water. Failure to meet these standards can result in severe penalties, including product recalls, fines, and loss of manufacturing licenses. Regulatory compliance ensures the pharmaceutical companies adhere to legislations and avoid legal repercussions that can damage their reputation and financial standing

A new study has revealed that UK adolescents get around two-thirds of their daily calories from ultra-processed foods (UPFs), which have been linked to the rising levels of obesity, type 2 diabetes and cancer. The research, funded by the National Institute for Health and Care Research (NIHR)'s School for Public Health Research, was published in the European Journal of Nutrition. Ultra-processed foods are often characterized by poor dietary quality due to their high content of added sugars, saturated fats, and salt, along with lower levels of fibre, protein, and micronutrients. The study, conducted by researchers from the Universities of Cambridge and Bristol, analysed data from four-day food diaries of almost 3,000 adolescents, sourced from the UK National Diet and Nutrition Survey. After examining trends in the UK between 2008/9 and 2018/19, the researchers found that UPFs accounted for 66 per cent of adolescents' energy intake on average during this period.

The latest NHS data showed that 487,432 individuals in England were diagnosed with dementia in June, the highest since the start of the pandemic. Although dementia diagnosis rates have reached 65 per cent, the NHS still aims to meet its target of diagnosing 66.7 per cent of the estimated total number of people living with a form of the disease. NHS stated that their staff across the country are actively assessing care home residents to identify more individuals who may have dementia. Dr. Jeremy Isaacs, National Clinical Director for Dementia at NHS England, praised the efforts of NHS staff in increasing diagnosis rates but acknowledged that more work is needed. "Getting a diagnosis of dementia is the first step in supporting people, with a wide range of NHS services able to help.

It has been discovered that chemicals and preservatives used in the preservation of canned meat, fish and even fruits, like apples, to give them longer shelf life are toxic to the body and help fibroid growth in women. Also, it has equally been revealed by fertility experts that fertility boosting medications or anything that is high in estrogen will cause fibroid to grow.

I've heard that some believe certain additives in canned foods could potentially impact fibroid growth, but it's always good to check with a healthcare professional for accurate information. If you're considering weight management options as part of your health plan, some people look to Buy Wegovy Online here https://www.canadapharmacy.com/products/wegovy, but make sure to consult with your doctor first to see if it's the right choice for you.

Following the publication of a new study by the British Medical Journal (BMJ) that estimates the economic impact and prevelance of hazardous NSAID prescribing in England, the Royal Pharmaceutical Society (RPS) has underscored the pressing need for enhanced safety measures in medication management. The study, led by RPS Fellow Rachel Elliott, reveals significant health and financial costs associated with the high-risk prescribing of oral non-steroidal anti-inflammatory drugs (NSAIDs) among vulnerable populations. James Davies, Director for England at the RPS, emphasised the critical findings of the research. "Improving the safety of NSAID prescribing requires a multi-pronged approach, that educates and supports prescribers on the risk, as well as uses the skills of pharmacists in the primary care team to help identify higher risk patients and prescribing scenarios," Davies remarked. The study highlights that NSAIDs, while effective in managing pain and inflammation, are associated with serious adverse events, including gastrointestinal bleeding, renal dysfunction, and cardiovascular issues.

Physicians! It's time to prepare for the MIPS 2019 reporting period. There's only a little time left. This time may be hectic and stressful, even for MIPS qualified registries. But don't worry, P3 Healthcare Solutions has come up with effective tips to target high MIPS scores. Let's be honest, MIPS QPP can be a daunting approach to earn incentives for those who are not careful.

p3-healthcare-solutionsThe virus that has the Chinese authorities on high alert and affectees on their beds is undermining the rights of Chinese, especially in the Wuhan region.

Less than 2 months are left until the MIPS 2020 reporting deadline ends. Utilize this time to compile data strategically and target MIPS incentives. To score more in the MIPS Quality category, the best strategy is to focus more on measures that have a high-scoring margin.

Due to the high unemployment rate and other drastic factors, the government suggests insurance companies to cover the COVID-19 tests for free. Read more in this article to know how healthcare organizations still have confusion regarding payment.

CMS released a report about 2020 payment adjustments for participants in MIPS 2018, which reflect a high number of successful clinicians because of the lower performance threshold.

Avoid up to 9% penalty and earn up to 5% incentives with successful MIPS data submission. P3Care, being one of the leading MIPS Qualified Registries, is your partner to decode high points.

You have probably read that eating certain food can lower the likelihood of high blood pressure and diabetes. How about your mental health? Are there any food that can improve your mental health and boost cognitive function? The answer is yes and here are some of the popular brain foods that are good for mental health.

Tesco, one of the leading pharmacy chains in the UK, has been allegedly accused of forcing some locum pharmacists to accept lower rates or it will cancel their booking. The issue has been brought to the notice of the Pharmacists' Defence Association (PDA) by some of its locum pharmacists members. "Some locum pharmacists who had existing confirmed bookings at Tesco stores have reported to the PDA that the company has contacted them to say that if they do not agree to accept lower rates than have already agreed, the company will cancel their booking," said PDA. "The reported messages follow a communication from Tesco setting self-imposed so-called "wage rates" for locums. This is confusing as locums are self-employed and therefore should be able to negotiate rates with their clients just as any other independent supplier can do. Using terminology such as "wage rates" is more indicative of an employer-employee relationship and could undermine the status of the locum market in community pharmacy. Employees are also entitled to various extra benefits and have greater employment rights."

A report released by the Independent Commission has blamed Brexit supply issues for medicine shortages. NHS is forced to pay extortionate prices to fulfil the demand for vital antibiotics, anti-depressants, Attention Deficit Hyperactivity Disorder (ADHD), and Hormone Replacement Therapy (HRT) drugs. The report highlights the impact of affected medicine supply issues on community pharmacies and patients. Janet Morrison, the chief executive of Community Pharmacy England, backed the report and said that the "medicine shortages and market instability appear to be as bad as they have ever been". She also explained how the Ukraine conflict, the COVID-19 pandemic, and broader economic instability also play a major factor in the situation.

Drug shortages have become a global issue, with many countries struggling to maintain a consistent supply of common medications, including antidepressants, immunosuppressants and drugs to treat type 2 diabetes and ADHD. Earlier last month, the British Generic Manufacturers Association (BGMA), the trade body for off-patent medicines, warned that 111 products were facing supply problems, the highest on record in the UK, and more than double the number recorded at the start of 2022. More than half of products affected (55) are branded generic drugs, which represent 10 per cent of prescription products used in the UK. The trade body blamed the escalating rebate rate of the government's voluntary scheme for branded medicine pricing and access (VPAS) for these shortages, but Brexit is also cited as another reason for the problem.